The US moringa-powder Salmonella outbreak is over—but recalled products may remain
The FDA and CDC closed the investigation after 131 reported cases across 38 states. The products have long shelf lives.
Anecdotal editorial image
The answer first
The investigation closed on 22 July 2026 after 131 reported infections, including 36 hospitalisations and no deaths. Recalled powders and capsules may still be in homes because their expiry dates run into 2028.
Why it matters
An outbreak can be declared over while the underlying products remain usable and stored. Consumers need the affected brands and lot guidance, not only the closure headline.
What the final update says
The FDA and CDC linked illnesses to recalled dietary supplements containing moringa leaf powder imported from India. Of 84 people interviewed across the investigation, 74 reported consuming a product containing moringa powder. Testing identified outbreak strains in finished products and ingredient samples.
The recalled list includes Live it Up Super Greens products and products from Why Not Natural and TNVitamins. Because some products carry expiry dates from August 2026 to January 2028, the FDA continues to tell consumers and retailers not to eat, sell or serve the affected products.
What changed—and what did not
The outbreak investigation is complete, which means investigators are no longer identifying ongoing illnesses connected to current exposure. It does not mean recalled stock has automatically disappeared. The FDA has increased screening of imported moringa powder from India for Salmonella.
Anyone checking a product should use the FDA page for the current brand, lot and expiry details. Anecdotal does not reproduce partial recall tables because they can change and should not replace the regulator’s live notice.
Summarised from the FDA’s final outbreak update.
Primary sources
Check the underlying record.
- 01Outbreak Investigation of Salmonella: Moringa Leaf Powderregulator
US Food and Drug Administration · 2026-07-22
Keep following the change
Get the most material safety & regulation updates in the free Anecdotal Briefing.
We never sell or share your email. Unsubscribe in one click.
Keep reading
Related intelligence.
FDA expands its import alert for supplements containing undeclared drug ingredients
The July update covers products marketed for sexual enhancement, weight loss, muscle building and other uses.
FDA says Addall supplements contained undeclared stimulant-like ingredients
Testing found DMAA, DMHA and phenibut across two products; only one was voluntarily recalled.
The UK has rewritten its consumer guide to food supplements
The June guidance explains authorised claims, interactions and why supplement labels cannot promise to treat symptoms.